IGC Pharma
26 hedge funds and large institutions have $937K invested in IGC Pharma in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
28% less capital invested
Capital invested by funds: $1.31M → $937K (-$373K)
Holders
26
Holding in Top 10
–
Calls
$128K
Puts
$19K
Top Buyers
| 1 | +$26.6K | |
| 2 | +$25.5K | |
| 3 | +$9.64K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$7.22K |
| 5 |
BlackRock
New York
|
+$4.75K |
Top Sellers
| 1 | -$52K | |
| 2 | -$40.3K | |
| 3 | -$17.8K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.36K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$6.05K |